Neptune and Enzymotec end dispute over krill patents

|About: Enzymotec Ltd. (ENZY)|By:, SA News Editor

Neptune Technologies & Bioressources (NEPT -0.7%) and Enzymotec (ENZY -4.5%) have agreed to end their patent litigation by entering into a broad cross-licensing agreement granting each a global royalty-free license to the other's krill-related patents. Under the terms of the deal, Enzymotec will make a one-time payment of $1.63M to Neptune.